血管内外周T细胞淋巴瘤非特指型的临床病理特征
回顾性分析1例原发于淋巴结的血管内外周T细胞淋巴瘤非特指型(IVPTCL,NOS)的临床病理特点并复习文献。患者为66岁男性,肿瘤细胞表达CD3、CD43、CD8、GrB、TIA-1及穿孔素,EBER阴性,TCR基因重排阳性,予CHOP联合西达本胺化疗后不足2个月死于感染和心肺功能衰竭。文献汇总56例血管内NK/T细胞淋巴瘤,本例为第2例IVPTCL,NOS且为首例原发于淋巴结者。
要点
- IVPTCL,NOS可原发于淋巴结,肿瘤细胞局限于血管腔内生长。
- 免疫表型为CD3、CD43、CD8、GrB、TIA-1、穿孔素阳性,EBER阴性。
- 本病高度侵袭,CHOP联合西达本胺治疗下患者不足2个月死亡。
核心结论
- 血管内NK/T细胞淋巴瘤为高度侵袭性疾病,目前尚无有效治疗方案。
- 本例为第2例报道的IVPTCL,NOS,且为第1例原发于淋巴结内的病例。
研究设计与样本
- 回顾性分析1例原发于淋巴结内的IVPTCL,NOS患者的临床及病理学特点。
- 复习相关文献,收集有明确分型的血管内NK/T细胞淋巴瘤56例。
主要发现
- 患者男性66岁,PET-CT示全身多发淋巴结肿大,活检示正常淋巴结结构消失、淋巴滤泡部分破坏。
- 高倍镜下大量血管弥漫增生扩张,异型淋巴样细胞团局限于管腔内,部分浸润大血管壁。
- 肿瘤细胞表达CD3、CD43、CD8、GrB、TIA-1及穿孔素,EBER阴性,TCR基因重排阳性。
- 56例文献病例中鼻型结外NK/T细胞淋巴瘤47例(男27例、女20例),间变性大细胞淋巴瘤8例(男3例、女5例),原发于脑的IVPTCL,NOS仅1例。
- 患者予CHOP联合西达本胺方案化疗,不足2个月因感染、心肺功能衰竭死亡。
关键数值与推荐
- 免疫组化阳性指标:CD3、CD43、CD8、GrB、TIA-1、穿孔素。
- EBV-EBER原位杂交阴性,TCR基因重排检测阳性。
临床怎么用
- 对血管腔内异型淋巴样细胞增生且正常淋巴结结构消失的病例应警惕IVPTCL,NOS。
- 需结合免疫组化CD3、CD43、CD8、GrB、TIA-1、穿孔素及EBER、TCR基因重排检测辅助诊断。
局限性
- 仅为单例病例报道并复习文献,累及淋巴结的报道少,尚需积累更多病例进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To summarize the clinical and pathological features of intravascular NK and T cell lymphoma for better understanding of such disease to reduce misdiagnosis and miss-diagnosis. Methods: Clinical and pathological features were analyzed retrospectively in one case of intravascular peripheral T-cell lymphoma, not otherwise specified (IVPTCL, NOS) , with literatures review. Results: The case presented in this study was a 66-year-old man. PET/CT scan showed multiple lymph nodes enlargement throughout the body. Normal lymph node structure could not be observed by tissue biopsy, while lymph follicles were partially disrupted. High-power light microscope revealed a large number of blood vessels with diffuse proliferation and dilation, where atypical lymphoid cell mass was restricted in the lumen and partially infiltrated the large blood vessel wall. These tumor cells were medium to large with moderate cytoplasm. The nucleus was irregular, single or multiple nucleoli could be seen, chromatin was condensed, some were empty and bright, and mitotic figures could be seen. Immunohistochemical staining showed that the neoplastic cells were positive for expression of CD3, CD43, CD8, GrB, TIA-1 and perforin. EBER in situ hybridization result was negative. Polymerase chain reaction test identified a clonal gene rearrangement of T-cell receptor γ. The patient was treated with CHOP in combination with chidamide, but died of infection and cardiopulmonary failure within 2 months. 56 cases of intravascular NK/T cell lymphoma with definite classification were collected from relevant literatures, including 47 cases with nasal type of extranodal NK/T cell lymphoma (27 were male and 20 were female) , 8 cases with anaplastic large cell lymphoma (3 males and 5 females) , and only one case with de nova IVPTCL, NOS in brain. We report the second case of IVPTCL,NOS, and notably originated from lymph node for the first time. Conclusions: Intravascular NK/T cell lymphoma is a highly aggressive disease with no effective treatment at present. Involvement of Lymph node has rarely been reported, and further studies on more cases are necessary. 目的: 总结血管内T细胞和NK细胞淋巴瘤的临床病理特点,增加对此类疾病的认识,以减少漏诊、误诊。 方法: 回顾性分析1例原发于淋巴结内的血管内外周T细胞淋巴瘤,非特指型(IVPTCL,NOS)患者的临床及病理学特点,并复习相关文献资料。 结果: 患者,男性,66岁,PET-CT示全身多发淋巴结肿大,活检示正常淋巴结结构消失,淋巴滤泡部分破坏。高倍镜下显示大量血管弥漫增生、扩张,其内见异型淋巴样细胞团局限生长于管腔内,部分浸润大血管壁,细胞中等偏大,胞质中等,核不规则,可见单个或多个核仁,染色质呈凝聚状,部分空亮,核分裂象可见。肿瘤细胞表达CD3、CD43、CD8、GrB、TIA-1及穿孔素等;原位杂交EBV-EBER(-);TCR基因重排检测(+)。予CHOP联合西达本胺方案化疗,患者不足2个月因感染、心肺功能衰竭死亡。检索相关文献,收集到有明确分型的血管内T细胞和NK细胞淋巴瘤56例,其中鼻型结外NK/T细胞淋巴瘤47例(男性27例,女性20例),间变性大细胞淋巴瘤8例(男性3例,女性5例),仅有1例为原发于脑组织的IVPTCL,NOS。本例为第2例报道的IVPTCL,NOS,且为第1例原发于淋巴结内的病例报道。 结论: 血管内T细胞和NK细胞淋巴瘤为高度侵袭性疾病,目前尚无有效治疗方案。此病累及淋巴结的报道少,尚需积累更多病例进一步研究。.
引用
- Guan X, Yang YC, Qi Y, et al. [Clinicopathological features of intravascular peripheral T-cell lymphoma]. Zhonghua Xue Ye Xue Za Zhi. 2021. PMID: 34455746. doi:10.3760/cma.j.issn.0253-2727.2021.07.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。